intro title
SynCore focuses on creating values of new drug by R&D management and integration of technology resources. SynCore was established in 2008 and cofounded by Sinphar Group and National Health Research Institute (NHRI) Taiwan. SynCore’s pipeline concentrates on oncology, ophthalmology, and dermatology fields and currently looking for partners for future cooperation and co-development.